Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy

Harnessing chitosan and poly-(γ-glutamic acid)-based biomaterials towards cancer immunotherapy

Cancer-related immunosuppression is one of the most challenging aspects of cancer therapy, being one of the principal causes of disease relapse. Most recent immunotherapeutic strategies have been at the forefront of therapies to overcome this problem through targeting T cell-related pathways. Notwit...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Beatriz V. Lima, Maria J. Oliveira, Mário A. Barbosa, Raquel M. Gonçalves, Flávia Castro
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2022-08-01
Sraith:	Materials Today Advances
Ábhair:	Cancer therapy Cancer theranostics Immunomodulation Immune adjuvants
Rochtain ar líne:	http://www.sciencedirect.com/science/article/pii/S2590049822000480

Míreanna comhchosúla

Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy
de réir: Neelam Thakur, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics
de réir: Amreen Khan, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
de réir: Yiming Xu, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Terapia adjuvantă cu imunomodulatori în oncologie
de réir: Ioana Chiţescu, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy
de réir: Jin-Kyu Rhee, et al.
Foilsithe / Cruthaithe: (2014-12-01)

Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration
de réir: Chiara Mancino, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Editorial: Immunomodulatory Nanomaterials in Cancer Theranostics
de réir: Sudip Mukherjee, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Editorial: Responsive biomaterials for controlled release and cancer theranostics
de réir: Nansha Gao, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Poly lactic-co-glycolic acid-based nanoparticles as delivery systems for enhanced cancer immunotherapy
de réir: Lei Gao, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy
de réir: Keyan Miao, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Cancer Immunotherapy: Advances and Challenges
de réir: Binafsha Manzoor Syed
Foilsithe / Cruthaithe: (2024-03-01)

Next-Generation Adjuvants: Applying Engineering Methods to Create and Evaluate Novel Immunological Responses
de réir: Jeremiah Y. Kim, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Harnessing adjuvant-induced epigenetic modulation for enhanced immunity in vaccines and cancer therapy
de réir: Yasmine Megdiche, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Nano-loaded natural killer cells as carriers of indocyanine green for synergetic cancer immunotherapy and phototherapy
de réir: Shigao Huang, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Combining theranostic/particle therapy with immunotherapy for the treatment of GU malignancies
de réir: Karin A. Skalina, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy
de réir: Simon Heumos, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Potential applications of nanoparticles in cancer immunotherapy
de réir: Yimei Jia, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Use of adjuvants for immunotherapy
de réir: Luisa Circelli, et al.
Foilsithe / Cruthaithe: (2017-08-01)

ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine
de réir: Sehui Kim, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Effects of immunomodulators on the response induced by vaccines against autoimmune diseases
de réir: Dante J. Marciani
Foilsithe / Cruthaithe: (2017-10-01)

Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
de réir: Zili Gu, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Understanding and harnessing triple-negative breast cancer-related microbiota in oncology
de réir: Ciaran Devoy, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Lights and Shadows on the Sourcing of Silver Radioisotopes for Targeted Imaging and Therapy of Cancer: Production Routes and Separation Methods
de réir: Marianna Tosato, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Data-Driven Modeling of Breast Cancer Tumors Using Boolean Networks
de réir: Domenico Sgariglia, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Association of Systemic Inflammatory and Immune Indices With Survival in Canine Patients With Oral Melanoma, Treated With Experimental Immunotherapy Alone or Experimental Immunotherapy Plus Metronomic Chemotherapy
de réir: Jéssica Soares Garcia, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Neutrophil‐Targeting Semiconducting Polymer Nanotheranostics for NIR‐II Fluorescence Imaging‐Guided Photothermal‐NO‐Immunotherapy of Orthotopic Glioblastoma
de réir: Jiansheng Liu, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Harnessing Immunity to Treat Advanced Thyroid Cancer
de réir: Hiroki Komatsuda, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Nanotechnology-enhanced immunotherapy for metastatic cancer
de réir: Peisen Zhang, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
de réir: Navami Prabhakar Koyande, et al.
Foilsithe / Cruthaithe: (2022-10-01)

The New Age of -omics in Urothelial Cancer – Re-wording Its Diagnosis and Treatment
de réir: Theodora Katsila, et al.
Foilsithe / Cruthaithe: (2018-02-01)

ω3 polyunsaturated fatty acids as immunomodulators in colorectal cancer: new potential role in adjuvant therapies
de réir: Sandra Gessani
Foilsithe / Cruthaithe: (2016-11-01)

Harnessing the immune system in the battle against breast cancer
de réir: Elizabeth S Nakasone, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Smart Multifunctional Theranostics: Simultaneous Diagnosis and Therapy of Cancer
de réir: Yadollah Omidi
Foilsithe / Cruthaithe: (2011-09-01)

CpG-Based Nanovaccines for Cancer Immunotherapy
de réir: Chen W, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Editorial: Nanotechnology for Precision Cancer Therapy: Advances in Gene Therapy, Immunotherapy, and 3D Bioprinting
de réir: Ângela Sousa, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections
de réir: Monica C. Gestal, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Stimuli-responsive chitosan-based nanocarriers for cancer therapy
de réir: Marziyeh Fathi, et al.
Foilsithe / Cruthaithe: (2017-09-01)

Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
de réir: Nimeet Desai, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Tantalum–Zirconium Co‐Doped Metal–Organic Frameworks Sequentially Sensitize Radio–Radiodynamic–Immunotherapy for Metastatic Osteosarcoma
de réir: Tao Li, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Recent advances of nanovaccines on cancer theranostics
de réir: Xiaobing Yuan, et al.
Foilsithe / Cruthaithe: (2025-02-01)